Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KL-1333M by Abliva for Mitochondrial Diseases: Likelihood of Approval
KL-1333M is under clinical development by Abliva and currently in Phase I for Mitochondrial Diseases. According to GlobalData, Phase I...
KL-1333M by Abliva for Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome: Likelihood of Approval
KL-1333M is under clinical development by Abliva and currently in Phase III for Myoclonic Epilepsy with Ragged Red Fibers (MERRF)...
KL-1333M by Abliva for Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome: Likelihood of Approval
KL-1333M is under clinical development by Abliva and currently in Phase II for Myoclonic Epilepsy with Ragged Red Fibers (MERRF)...
KL-1333M by Abliva for Mitochondrial Diseases: Likelihood of Approval
KL-1333M is under clinical development by Abliva and currently in Phase II for Mitochondrial Diseases. According to GlobalData, Phase II...